EMA official links AstraZeneca vaccine to blood clots

The European Medicines Agency (EMA) head of vaccines Marco Cavalerion Tuesday said the regulator sees potential link between the AstraZeneca COVID-19 vaccine and increased risk of blood clots, Italian newspaper Messaggero reported.

The European Union has blocked shipments of 3.1 million doses of AstraZeneca's COVID-19 vaccine to Australia and the country has little hope of getting the remaining 400,000 doses it has been pledged on time, reported Reuters citing a government source on Tuesday.